Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Hearing On Breast Cancer Drug Set For This Week
Genentech, the maker of Avastin, will appeal to the Food and Drug Administration to make its drug available as a treatment for breast cancer - asking for one more chance to prove its efficacy.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
